Cargando…

NF-κB/c-Rel deficiency causes Parkinson’s disease-like prodromal symptoms and progressive pathology in mice

BACKGROUND: Parkinson’s disease (PD), the most common neurodegenerative movement disorder, is characterized by dopaminergic nigrostriatal neuron loss and brain accumulation of Lewy bodies, protein aggregates mainly composed of α-synuclein. We reported that mice deficient for NF-κB/c-Rel (c-rel(-/-))...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parrella, Edoardo, Bellucci, Arianna, Porrini, Vanessa, Benarese, Marina, Lanzillotta, Annamaria, Faustini, Gaia, Longhena, Francesca, Abate, Giulia, Uberti, Daniela, Pizzi, Marina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530198/ https://www.ncbi.nlm.nih.gov/pubmed/31139367 http://dx.doi.org/10.1186/s40035-019-0154-z

Ejemplares similares

NF-κB in Innate Neuroprotection and Age-Related Neurodegenerative Diseases
por: Lanzillotta, Annamaria, et al.
Publicado: (2015)

Age-Dependent Neuropsychiatric Symptoms in the NF-κB/c-Rel Knockout Mouse Model of Parkinson’s Disease
por: Parrella, Edoardo, et al.
Publicado: (2022)

Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease
por: Bellucci, Arianna, et al.
Publicado: (2020)

Mild Inflammatory Profile without Gliosis in the c-Rel Deficient Mouse Modeling a Late-Onset Parkinsonism
por: Porrini, Vanessa, et al.
Publicado: (2017)

Late-onset Parkinsonism in NFκB/c-Rel-deficient mice
por: Baiguera, Cristina, et al.
Publicado: (2012)

A Polyphenol-Enriched Supplement Exerts Potent Epigenetic-Protective Activity in a Cell-Based Model of Brain Ischemia
por: Faggi, Lara, et al.
Publicado: (2019)

Neuroprotective and Anti-Apoptotic Effects of CSP-1103 in Primary Cortical Neurons Exposed to Oxygen and Glucose Deprivation
por: Porrini, Vanessa, et al.
Publicado: (2017)

The Role of Mast Cells in Stroke
por: Parrella, Edoardo, et al.
Publicado: (2019)

Neuroprotective epi-drugs quench the inflammatory response and microglial/macrophage activation in a mouse model of permanent brain ischemia
por: Mota, Mariana, et al.
Publicado: (2020)

Dopamine Transporter/α-Synuclein Complexes Are Altered in the Post Mortem Caudate Putamen of Parkinson’s Disease: An In Situ Proximity Ligation Assay Study
por: Longhena, Francesca, et al.
Publicado: (2018)

From Preclinical Stroke Models to Humans: Polyphenols in the Prevention and Treatment of Stroke
por: Parrella, Edoardo, et al.
Publicado: (2020)

1B/(−)IRE DMT1 Expression during Brain Ischemia Contributes to Cell Death Mediated by NF-κB/RelA Acetylation at Lys310
por: Ingrassia, Rosaria, et al.
Publicado: (2012)

The Contribution of α-Synuclein Spreading to Parkinson's Disease Synaptopathy
por: Longhena, Francesca, et al.
Publicado: (2017)

The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injury
por: Lanzillotta, A, et al.
Publicado: (2010)

Alpha-Synuclein in the Regulation of Brain Endothelial and Perivascular Cells: Gaps and Future Perspectives
por: Bogale, Tizibt Ashine, et al.
Publicado: (2021)

Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?
por: Brembati, Viviana, et al.
Publicado: (2023)

Synergistic Association of Valproate and Resveratrol Reduces Brain Injury in Ischemic Stroke
por: Faggi, Lara, et al.
Publicado: (2018)

Study of alpha-synuclein fibrillation: state of the art and expectations
por: Longhena, Francesca, et al.
Publicado: (2019)

Synergistic association of resveratrol and histone deacetylase inhibitors as treatment in amyotrophic lateral sclerosis
por: Parrella, Edoardo, et al.
Publicado: (2022)

Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotype
por: Faustini, Gaia, et al.
Publicado: (2022)

Synapsin III Regulates Dopaminergic Neuron Development in Vertebrates
por: Faustini, Gaia, et al.
Publicado: (2022)

Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson’s Disease
por: Brembati, Viviana, et al.
Publicado: (2023)

Living in Promiscuity: The Multiple Partners of Alpha-Synuclein at the Synapse in Physiology and Pathology
por: Longhena, Francesca, et al.
Publicado: (2019)

Mitochondria and α-Synuclein: Friends or Foes in the Pathogenesis of Parkinson’s Disease?
por: Faustini, Gaia, et al.
Publicado: (2017)

Pharmacological targeting of the β-amyloid precursor protein intracellular domain
por: Branca, Caterina, et al.
Publicado: (2014)

Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First?
por: Zaltieri, Michela, et al.
Publicado: (2015)

Acetylation state of RelA modulated by epigenetic drugs prolongs survival and induces a neuroprotective effect on ALS murine model
por: Schiaffino, Lorenzo, et al.
Publicado: (2018)

NF-κB/Rel Transcription Factors in Pancreatic Cancer: Focusing on RelA, c-Rel, and RelB
por: Kabacaoglu, Derya, et al.
Publicado: (2019)

Alpha-Synuclein Preserves Mitochondrial Fusion and Function in Neuronal Cells
por: Faustini, Gaia, et al.
Publicado: (2019)

The RelB subunit of NFκB acts as a negative regulator of circadian gene expression
por: Bellet, Marina M., et al.
Publicado: (2012)

The Role of Rab Proteins in Parkinson’s Disease Synaptopathy
por: Bellucci, Arianna, et al.
Publicado: (2022)

NF-κB/Rel-Mediated Regulation of the Neural Fate in Drosophila
por: Ayyar, Savita, et al.
Publicado: (2007)

Regulation of Immune Responses by NF-κB/Rel Transcription Factors
por: Sha, William C.
Publicado: (1998)

Rel/NF-κB Transcription Factors Emerged at the Onset of Opisthokonts
por: Leger, Michelle M, et al.
Publicado: (2022)

Pro-survival and anti-inflammatory roles of NF-κB c-Rel in the Parkinson's disease models
por: Wang, Zishan, et al.
Publicado: (2020)

Cell transformation by v-Rel reveals distinct roles of AP-1 family members in Rel/NF-κB oncogenesis
por: Liss, Andrew S., et al.
Publicado: (2010)

NF-κB Repression by PIAS3 Mediated RelA SUMOylation
por: Liu, Yuangang, et al.
Publicado: (2012)

Foxp3 Interacts with c-Rel to Mediate NF-κB Repression
por: Loizou, Louiza, et al.
Publicado: (2011)

The NF-κB RelB Protein Is an Oncogenic Driver of Mesenchymal Glioma
por: Lee, Dong Whan, et al.
Publicado: (2013)

MicroRNA-34a-5p expression in the plasma and in its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study
por: Grossi, Ilaria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4ssncdvdhhjm8qrk2shvaah5es